NL-OMON48010已完成不适用
The pharmacokinetics and pharmacodynamics of eculizumab in patients with paroxysmal nocturnal hemoglobinuria. - PREPARE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •The patient has a diagnosis of PNH
- •The patient is treated with eculizumab
- •Willing to give informed consent
排除标准
- •Not applicable
研究者
相似试验
进行中（未招募）
不适用
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
进行中（未招募）
不适用
Pharmacokinetics, pharmacodynamics and safety of intra-articular multiple doses of 500 mcg icatibant in an uncontrolled 13-week multi-center study in patients with symptomatic knee osteoarthritis - TRICAPEKAEUCTR2006-000763-29-LTSanofi-Aventis Deutschland GmbH12
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
尚未招募
不适用
Pharmacokinetics and Pharmacodynamics of Medication in Asphyxiated Newborns During Controlled Hypothermia PharmaCool National Multicenter Study.medication metabolism during the intensive care treatment of resuscitated newborns1001033510028920NL-OMON34433Academisch Medisch Centrum270
撤回
不适用
Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (formerly known as CB-1158) as a Single Agent and in Combination with Immune Checkpoint Therapy in Patients with Advanced/Metastatic Solid TumorsNL-OMON48697Incyte Corporation12